Related Experiment Video

Updated: May 24, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Antisense technologies targeting fatty acid synthetic enzymes

Jinshun Lin1, Feng Liu, Yuyang Jiang

  • 1Guangdong Provincial Key Laboratory of Chemical Biology, Tsinghua University Graduate School at Shenzhen, Shenzhen, 518055, PR China.

Recent Patents on Anti-Cancer Drug Discovery
|February 21, 2012
PubMed

Insights

Antisense agents specifically inhibit gene expression, offering potential cancer therapies by targeting fatty acid synthesis enzymes. This review covers their applications and related patents, including those targeting miR-122.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Fatty acid synthesis involves multiple enzymes crucial for tumor growth.
  • Overexpression of these enzymes makes them targets for cancer therapy.
  • Antisense agents offer specific gene expression inhibition for research and therapy.

Purpose of the Study:

  • To review antisense agents for modulating fatty acid synthesis.
  • To discuss patents related to antisense agents targeting fatty acid synthetic enzymes.
  • To explore antisense agents targeting miR-122 for cancer therapy.

Main Methods:

  • Review of scientific literature on antisense agents and fatty acid synthesis.
  • Analysis of patents concerning antisense agents and fatty acid synthetic enzymes.
  • Examination of studies on miR-122's role in fatty acid synthesis regulation.

Main Results:

  • Antisense agents are effective tools for studying gene function and potential cancer therapeutics.
  • Various antisense agents can modulate fatty acid synthesis pathways.
  • Patents exist for antisense agents targeting key fatty acid synthetic enzymes and miR-122.

Conclusions:

  • Antisense technology holds promise for cancer treatment by targeting fatty acid synthesis.
  • Further research and development of antisense agents are warranted.
  • Inhibition of miR-122 represents a novel therapeutic strategy in this area.

More Related Videos

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues12:07

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues

Published on: November 22, 2014

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...